Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXEL | Common Stock | Sale | -$104K | -4.72K | -0.76% | $22.00 | 619K | Mar 28, 2022 | Direct | F1, F2 |
transaction | EXEL | Common Stock | Sale | -$292K | -13.3K | -2.15% | $22.00 | 605K | Mar 29, 2022 | Direct | F1 |
holding | EXEL | Common Stock | 999 | Mar 28, 2022 | By 401(k) | F3 |
Id | Content |
---|---|
F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2020. |
F2 | Includes 144,482 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
F3 | Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 28, 2022. |